L64 Androgenic alopecia. Drug-induced androgenic alopecia
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Androgenic alopecia male patients between 18 and 45 years old Have not used topical, intralesional or systemic treatment for permanent hair or color during and 6 months before the study. Patient satisfaction AGA diagnosis based on Norwood Hamilton criteria grade 2 to 6 Patients with no history of treatment with drugs known to interfere with BTA in the past 6 months
Exclusion criteria
Exclusion criteria: Patients with severe diseases of internal organs, eyes or skin Botulinum toxin contraindications include hypersensitivity reactions Patients with neuromuscular disorders (such as Eaton Lambert and myasthenia gravis, etc.) Patients with injection site infection Patients taking aminoglycosides, anticholinergic drugs, muscle relaxants and calcium channel blockers Patients who use drugs such as aspirin, warfarin, steroids, oral retinoid, hormonal or cytotoxic drugs, patients who present with Köbner's phenomenon, thromboembolic manifestations Diseases of the neuromuscular system; Inflammation, infection, or unhealed sores on the skin around the injection site on the head
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| From hair count statistics and objective score of head photos. Timepoint: Before and after study. Method of measurement: Professional photography camera and tripod (to ensure the same angle and distance for taking pictures) and taking pictures from fixed locations. | — |
Countries
Iran (Islamic Republic of)
Contacts
Mashhad University of Medical Sciences